Author

E. Kiner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Bhagwat· 1 shared A. Clark· 1 shared A. F. Carlin· 1 shared a. horowitz· 1 shared A. Roitburd-Berman· 1 shared A. Soto· 1 shared A. Tocheva· 1 shared A. Tsankov· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhagwat

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell view of tumor microenvironment gradients in pleural mesothelioma

B. Giotti, K. Dolasia, w. Zhao, P. Cai, R. Sweeney, E. Merritt, E. Kiner, G. Kim, A. Bhagwat, S. Hegde, B. Fitzgerald, S. Shroff, T. Dawson, M. Garcia-Barros, J. Abdul-Ghafar, , A. Tsankov

This paper uses single-cell RNA-sequencing to analyze the tumor microenvironment in pleural mesothelioma, identifying gene programs, fetal-like endothelial cells, and a new therapeutic target.

bioRxiv · Mar 14, 2024Cancer Biology

Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors

M. Mor, M. Werbner, J. Alter, M. Safra, E. Chomsky, S. Hada-Neeman, K. Polonsky, C. Nowell, A. Clark, A. Roitburd-Berman, N. Ben-Shalom, M. Navon, D. Rafael, H. Sharim, E. Kiner, , N. Freund

This study identifies multi-clonal neutralizing antibodies against SARS-CoV-2 in severe COVID-19 patients and shows their potential for combination therapy.

bioRxiv · Oct 6, 2020Immunology